Vitality Re VII Ltd


Vitality Re VII ILS helps Aetna reduce required capital & gain reinsurance

Health insurance company Aetna has hailed the completion of its latest ILS transaction, Vitality Re VII Ltd. (Series 2016-1), which it says help it to "reduce its required capital" while gaining a $200m source of collateralized excess of loss reinsurance. The Vitality Re II 2016-1 health insurance loss ratio linked ILS, read the full article →

Aetna’s Vitality Re VII medical benefit cat bond prices at top-end

Health insurance firm Aetna's $200m Vitality Re VII Ltd. (Series 2016-1) health insurance medical benefit ratio catastrophe bond deal has now been priced, with the coupon settling at the upper end of the initial guidance range. When this ILS deal launched almost a fortnight ago, it saw Aetna seeking to gain read the full article →

Aetna back with $200m Vitality Re VII health insurance linked ILS

Health insurance firm Aetna is returning to the capital markets in search of another $200 million or more of fully-collateralised reinsurance protection for losses under its health insurance medical benefit ratio, through a Vitality Re VII Ltd. (Series 2016-1) ILS issuance. Aetna has been using the insurance-linked securities (ILS) market as read the full article →